1-3 of 3
Bogdan Ene-Iordache
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes: A prospective randomized double-blind clinical trial

Open Access
Piero Ruggenenti, MD, Dario Cattaneo, PHD, Stefano Rota, MD, Ilian Iliev, MD, Aneliya Parvanova, MD, Olimpia Diadei, CHEMD, Bogdan Ene-Iordache, ENGD, Silvia Ferrari, CHEMIST, Antonio C. Bossi, MD, Roberto Trevisan, MD, Antonio Belviso, MD, Giuseppe Remuzzi, MD, FRCP, for the Ezetimibe and Simvastatin in Dyslipidemia of Diabetes (ESD) Study Group
Journal: Diabetes Care
Diabetes Care 2010;33(9):1954–1956
https://doi.org/10.2337/dc10-0320
Published: 21 June 2010
View articletitled, Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes: A prospective randomized double-blind clinical trial
Open the PDF for Effects of Combined Ezetimibe and Simvastatin Therapy as Compared With Simvastatin Alone in Patients With Type 2 Diabetes: A prospective randomized double-blind clinical trial in another window
Includes: Supplementary data
Journal Articles

Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 Diabetes: A prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT)

Free
Piero Ruggenenti, MD, Ilian Iliev, MD, Grazia Maria Costa, MD, Aneliya Parvanova, MD, Annalisa Perna, STAT SCI D, Giovanni Antonio Giuliano, DIPL STAT, Nicola Motterlini, STAT SCI D, Bogdan Ene-Iordache, ENG D, Giuseppe Remuzzi, MD, FRCP, the BENEDICT Study Group
Journal: Diabetes Care
Diabetes Care 2008;31(8):1629–1634
https://doi.org/10.2337/dc08-0371
Published: 01 August 2008
View articletitled, Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 Diabetes: A prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT)
Open the PDF for Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 Diabetes: A prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT) in another window
Includes: Supplementary data
Journal Articles

Renal and Metabolic Effects of Insulin Lispro in Type 2 Diabetic Subjects With Overt Nephropathy

Free
Piero Ruggenenti, MD, Claudio Flores, MD, Claudio Aros, MD, Bogdan Ene-Iordache, ENG.D, Roberto Trevisan, MD, Cosimo Ottomano, MD, Giuseppe Remuzzi, MD
Journal: Diabetes Care
Diabetes Care 2003;26(2):502–509
https://doi.org/10.2337/diacare.26.2.502
Published: 01 February 2003
View articletitled, Renal and Metabolic Effects of Insulin Lispro in Type 2 Diabetic Subjects With Overt Nephropathy
Open the PDF for Renal and Metabolic Effects of Insulin Lispro in Type 2 Diabetic Subjects With Overt Nephropathy in another window